Medistim ASA (OSL: MEDI)

Market Cap	2.72B
Revenue (ttm)	541.82M
Net Income (ttm)	101.64M
Shares Out	18.31M
EPS (ttm)	5.55
PE Ratio	26.75
Forward PE	23.68
Dividend	4.50 (3.03%)
Ex-Dividend Date	Apr 25, 2024

Volume	686
Average Volume	7,320
Open	152.00
Previous Close	148.00
Day's Range	148.50 - 152.00
52-Week Range	130.00 - 227.00
Beta	0.99
RSI	45.65
Earnings Date	Feb 28, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 151
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2023, Medistim ASA's revenue was 521.11 million, an increase of 7.17% compared to the previous year's 486.26 million. Earnings were 103.82 million, a decrease of -8.91%.